Go Pro

Icon (ICLR) Stock Forecast & Price Target

Icon logo
$164.85 +1.27 (+0.78%)
As of 09/4/2026 04:00 PM Eastern

Icon - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Sell
2
Hold
7
Buy
8

Based on 17 Wall Street analysts who have issued ratings for Icon in the last 12 months, the stock has a consensus rating of "Hold." Out of the 17 analysts, 2 have given a sell rating, 7 have given a hold rating, 7 have given a buy rating, and 1 has given a strong buy rating for ICLR.

Consensus Price Target

$170.40
3.37% Upside
According to the 17 analysts' twelve-month price targets for Icon, the average price target is $170.40. The highest price target for ICLR is $209.00, while the lowest price target for ICLR is $100.00. The average price target represents a forecasted upside of 3.37% from the current price of $164.85.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for ICLR and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Icon and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ICLR Analyst Ratings Over Time

TypeCurrent Forecast
9/6/25 to 9/6/26
1 Month Ago
8/7/25 to 8/7/26
3 Months Ago
6/8/25 to 6/8/26
1 Year Ago
9/6/24 to 9/6/25
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
7 Buy rating(s)
7 Buy rating(s)
8 Buy rating(s)
9 Buy rating(s)
Hold
7 Hold rating(s)
7 Hold rating(s)
8 Hold rating(s)
5 Hold rating(s)
Sell
2 Sell rating(s)
2 Sell rating(s)
2 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$170.40$170.40$156.44$212.62
Forecasted Upside3.37% Upside3.58% Upside2.76% Upside21.58% Upside
Consensus RatingHoldHoldHoldModerate Buy

ICLR Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ICLR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Icon Stock vs. The Competition

TypeIconHealthcare CompaniesBroader Market
Consensus Rating Score
2.41
2.30
2.53
Consensus RatingHoldHoldModerate Buy
Predicted Upside3.37% Upside928.71% Upside14.03% Upside
News Sentiment Rating
Positive News

See Recent ICLR News
Positive News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
8/26/2026
Weiss Ratings logo
Weiss Ratings
5 of 5 stars
 Reiterated RatingSell (D)
7/31/2026
Robert W. Baird logo
Robert W. Baird
3 of 5 stars
Eric Coldwell
Eric Coldwell
4 of 5 stars
Set Target$194.00+17.42%
7/31/2026
Citigroup Inc. logo
Citigroup
4 of 5 stars
Patrick Donnelly
4 of 5 stars
Boost TargetNeutral$165.00 ➝ $180.00+8.74%
7/31/2026Reiterated RatingBuy$207.00 ➝ $209.00+26.26%
7/30/2026 UpgradeStrong-Buy
7/28/2026 UpgradeStrong SellHold
6/26/2026Boost TargetOutperform$180.00 ➝ $190.00+18.04%
6/25/2026Boost TargetOutperform$160.00 ➝ $187.00+14.75%
6/25/2026Boost TargetBuy$164.00 ➝ $197.00+24.55%
6/25/2026UpgradeSector PerformOutperform$126.00 ➝ $185.00+16.96%
6/25/2026Boost TargetEqual Weight$160.00 ➝ $175.00+10.64%
6/25/2026Boost TargetNeutral$130.00 ➝ $155.00-5.28%
6/25/2026Boost TargetUnderperform$125.00 ➝ $150.00-5.17%
6/24/2026 Set Target$160.00+12.15%
6/1/2026 Set Target$164.00+22.14%
5/29/2026 Reiterated RatingBuy$165.00+22.01%
5/28/2026 DowngradeNeutral
5/28/2026Set Target$145.00+6.18%
2/17/2026Set TargetBuyNeutral$100.00+7.53%
7/25/2025Boost TargetOutperform$170.00 ➝ $240.00+28.37%
5/2/2025Lower TargetNeutral$180.00 ➝ $160.00+9.30%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 06:39 AM ET.


Should I Buy Icon Stock? ICLR Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, September 4, 2026. Please send any questions or comments about these Icon pros and cons to contact@marketbeat.com.

Icon
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in ICON Public Limited:

  • ICON Public Limited shares are currently trading at $164.85, which is significantly above the 200-day moving average of $134.82, indicating strong recent momentum and a breakout from the lower price range seen earlier in the year.
  • The company recently reported quarterly earnings of $2.56 per share, beating the consensus estimate of $2.55, while also generating revenue of $2.06 billion, which exceeded the expected $2 billion, demonstrating consistent operational performance.
  • Institutional interest in the stock has surged, with Maple Rock Capital Partners Inc. increasing its holdings by 257.8% in the second quarter and Frontier Capital Management Co. raising its position by 97.6%, suggesting that large investors are gaining confidence in the company's outlook.
  • Short interest in the stock has decreased to 2,220,474 shares as of August 14, 2026, down from 3,240,155 shares in late June, which reduces the potential for a short squeeze and indicates that fewer investors are betting against the company's success.
  • ICON Public Limited has a low debt-to-equity ratio of 0.23, meaning the company relies less on borrowed money to fund its operations, which provides a financial cushion and reduces the risk of insolvency during economic downturns.

Icon
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in ICON Public Limited for these reasons:

  • The stock carries a high price-to-earnings ratio of 38.70, which is significantly above the market average, suggesting that investors are paying a premium for earnings that may not be sustainable if growth slows down.
  • Analysts have assigned a consensus rating of "Hold" with a target price of $170.40, which offers only a modest 3.4% upside from the current price of $164.85, indicating that the stock may be fairly valued with limited room for further appreciation.
  • Insiders have sold a total of 9,531 shares valued at $1,565,764 in the last 90 days, including sales by directors and the CFO, which could signal a lack of confidence in the company's future performance or a desire to lock in gains.
  • ICON Public Limited does not pay a dividend, with a yield of 0.00%, which may be unattractive to income-focused investors who prefer regular cash payments in addition to potential capital gains.
  • The company's beta of 1.20 indicates that its stock is 20% more volatile than the overall market, meaning investors should expect larger price swings and higher risk compared to less volatile stocks.

ICLR Forecast - Frequently Asked Questions

According to the research reports of 17 Wall Street equities research analysts, the average twelve-month stock price forecast for Icon is $170.40, with a high forecast of $209.00 and a low forecast of $100.00.

17 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Icon in the last twelve months. There are currently 2 sell ratings, 7 hold ratings, 7 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" ICLR shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ICLR, but not buy additional shares or sell existing shares.

According to analysts, Icon's stock has a predicted upside of 3.37% based on their 12-month stock forecasts.

Over the previous 90 days, Icon's stock had 5 upgrades by analysts.

Analysts like Icon more than other "healthcare" companies. The consensus rating score for Icon is 2.41 while the average consensus rating score for "healthcare" companies is 2.30. Learn more on how ICLR compares to other companies.


MarketBeat monitors more than a dozen sources for Icon analyst ratings, with the most recent rating issued on 8/26/2026.
From Our Partners